Literature DB >> 19146920

Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.

Martínez-Levy Gabriela1, Díaz-Galvis John, Briones-Velasco Magdalena, Gómez-Sánchez Ariadna, De la Peña-Olvera Francisco, Sosa-Mora Liz, Palacios-Cruz Lino, Ricardo-Garcell Josefina, Reyes-Zamorano Ernesto, Cruz-Fuentes Carlos.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a clinically complex and multifactorial psychiatric disorder of inattention, hyperactivity and impulsivity. Family, twin and adoption studies suggest a genetic influence in the etiology of ADHD. Two variable number of tandem repeats (VNTR) polymorphic systems have been frequently associated with this disorder: the 7 repeat (R) allele in exon 3 of the dopamine receptor D4 (DRD4) and the 10R allele located in the 3' untranslated region (UTR) of the dopamine transporter (DAT1). We conducted a case-control association study between ADHD and these polymorphisms in a group of adolescent inhabitants of the metropolitan area of Mexico City. In addition, we evaluated the interaction between these genes, the disorder and its associated psychiatric comorbidities. No positive association between ADHD and the 7R allele of DRD4 or the 10R allele of DAT1 was observed; however, compared to controls, patients with internalized comorbidities had a lesser frequency of genotypes with the 7R allele of DRD4 and the 10/10 genotype of DAT1. A logistic regression analysis showed that the simultaneous absence of the 10/10 DAT1 and 7/7 DRD4 genotypes predicts membership to the group of ADHD patients with internalized comorbidities (e.g. anxiety, depression). Our results highlight the importance of cross-ethnic research and the possibility of a distinct genetic basis that underlies the type of comorbidities associated with ADHD. This result should be considered in terms of the study design, and further replication is necessary in an independent sample.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19146920     DOI: 10.1016/j.neulet.2009.01.004

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

2.  Potential contribution of dopaminergic gene variants in ADHD core traits and co-morbidity: a study on eastern Indian probands.

Authors:  Subhamita Maitra; Kanyakumarika Sarkar; Paramita Ghosh; Arijit Karmakar; Animesh Bhattacharjee; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Cell Mol Neurobiol       Date:  2014-03-02       Impact factor: 5.046

Review 3.  Molecular genetics of attention-deficit/hyperactivity disorder: an overview.

Authors:  Tobias Banaschewski; Katja Becker; Susann Scherag; Barbara Franke; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-10       Impact factor: 4.785

Review 4.  Specific Genes Associated with Adverse Events of Methylphenidate Use in the Pediatric Population: A Systematic Literature Review.

Authors:  Beinta Joensen; Morten Meyer; Lise Aagaard
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

5.  Interaction effects of GIT1 and DRD4 gene variants on continuous performance test variables in patients with ADHD.

Authors:  Hyojin Kim; Johanna Inhyang Kim; Haebin Kim; Jae-Won Kim; Bung-Nyun Kim
Journal:  Brain Behav       Date:  2017-08-01       Impact factor: 2.708

6.  Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.

Authors:  Edna Grünblatt; Anna Maria Werling; Alexander Roth; Marcel Romanos; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2019-03-28       Impact factor: 3.575

7.  Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder.

Authors:  François Gonon; Jan-Pieter Konsman; David Cohen; Thomas Boraud
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

8.  DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.

Authors:  Darko Turic; James Swanson; Edmund Sonuga-Barke
Journal:  Pharmgenomics Pers Med       Date:  2010-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.